Emtricitabine/Tenofovir disoproxil Teva (emtricitabine/tenofovir disoproxil)

€67.20
In stock
SKU
Emtricitabine/Tenofovir disoproxil Teva

You can order Emtricitabine/Tenofovir disoproxil Teva from TheSocialMedwork if the drug has not been approved or is not available in your country. We help patients and doctors get access to medicines at the lowest price worldwide. 

Infectiology HIV/AIDS
Marketing Authorisation Holder Teva Pharmachemie
Mode of Action Antiviral
Administration Oral
Regulatory agency approval Medicines & Healthcare products Regulatory Agency (MHRA), United Kingdom, The Medicines Evaluation Board (MEB), The Netherlands
Strength 200 mg; 245 mg milligram
Package 30 Tablets

Disclaimer: Please note that in some countries the compound emtricitabine / tenofovir disoproxil is protected by patents registered by Gilead Sciences Inc. We cannot deliver emtricitabine/tenofovir disoproxil to a country where there is a valid patent registered. If you are unsure if a patent is registered in your country, please get in touch and we will find out for you.

What is Emtricitabine/Tenofovir disoproxil Teva (emtricitabine/tenofovir disoproxil) for?

Emtricitabine/tenofovir disoproxil Teva (emtricitabine/tenofovir disoproxil) is an antiviral medicine used in combination with at least one other antiviral medicine to treat adults infected with human immunodeficiency virus type 1 (HIV-1), the virus that causes acquired immune deficiency syndrome (AIDS)1,2. It is also used to help prevent sexually transmitted HIV-1 infection in adults who are at high risk of being infected (PrEP - pre-exposure prophylaxis). When used as PrEP it is recommended for use in combination with safer sex practices, such as the use of condoms1,2, which may protect against other sexually transmitted infections (STIs) as well as against HIV infection.

How does Emtricitabine/Tenofovir disoproxil Teva (emtricitabine/tenofovir disoproxil) work?

Each tablet of emtricitabine/tenofovir disoproxil contains two active substances, emtricitabine (200 mg) and tenofovir disoproxil (245 mg). Inside the body, tenofovir disoproxil is converted into the active substance tenofovir. Tenofovir and emtricitabine block the activity of the enzyme made by the virus to reproduce itself in the cells it has infected. Taken in combination with at least one other antiviral medicine, reduces the amount of HIV in the blood and keeps it at a low level. It does not cure HIV infection or AIDS but it can prevent damages to the immune system and the development of infections and diseases associated with AIDS1,2.

For the treatment of HIV-1 infection, emtricitabine/tenofovir disoproxil, taken in combination with at least one other antiviral medicine, reduces the amount of HIV in the blood and keeps it at a low level. It does not cure HIV infection or AIDS, but it can prevent damages to the immune system and the development of infections and diseases associated with AIDS1,2.

For HIV-1 infection prevention (PrEP), it is expected that emtricitabine / tenofovir disoproxil in the blood will stop the virus from multiplying and spreading from the site of infection in case the individual is exposed to the virus. The effectiveness of the combination of emtricitabine and tenofovir in reducing the risk of acquiring HIV-1 is strongly correlated with adherence as demonstrated by measurable drug levels in blood1,2.

Where has Emtricitabine/Tenofovir disoproxil Teva (emtricitabine/tenofovir disoproxil) been approved?

Emtricitabine/tenofovir disoproxil Teva was approved for the treatment of individuals infected with human immunodeficiency virus type 1 (HIV-1), in combination with at least one other antiviral medicine, and as pre-exposure prophylaxis (PrEP) in combination with safer sex practices to reduce the risk of sexually acquired HIV-1 in adults at high risk, among others, by:

  • MHRA (UK) April 19, 20161

  • CBG (NL) in September 29, 20162

How is Emtricitabine/Tenofovir disoproxil Teva (emtricitabine/tenofovir disoproxil) taken?

Complete information about Emtricitabine / tenofovir disoproxil Teva (emtricitabine/tenofovir disoproxil) dosage and administration can be found here1,2.

The standard dosage for both treatment and prevention of HIV-1 infection is:

  • 1 tablet 200 mg emtricitabine/ 245 mg tenofovir disoproxil once daily

The kidney function should be monitored in all patients. Patients using emtricitabine/tenofovir disoproxil for PrEP should be tested for HIV infection every 3 months1,2.

HIV-1 uninfected individuals should be counseled to strictly adhere to the recommended Emtricitabine/Tenofovir disoproxil Teva dosing schedule. The effectiveness of the combination of emtricitabine and tenofovir in reducing the risk of acquiring HIV-1 is strongly correlated with adherence as demonstrated by measurable drug levels in blood1,2.

Note: Consult your treating doctor for personalised dosing.

Are there any known side effects of Emtricitabine/Tenofovir disoproxil Teva (emtricitabine / tenofovir disoproxil)?

The most common side effects are1,2:

  • nausea
  • diarrhoea.

More Information
Working ingredient emtricitabine/tenofovir disoproxil
Shipping method Standard (not temperature controlled)
Package 30
Therapeutic Area Infectious diseases
Infectiology HIV/AIDS
Indication HIV-1 infection treatment or prevention (PrEP)
Administration Oral
Mode of Action Antiviral
Regulatory agency approval Medicines & Healthcare products Regulatory Agency (MHRA), United Kingdom, The Medicines Evaluation Board (MEB), The Netherlands
Marketing Authorisation Holder Teva Pharmachemie

The approvals of emtricitabine / tenofovir disoproxil for HIV-1 treatment

The approvals of emtricitabine/tenofovir disoproxil for HIV-1 treatment were based on studies that compared emtricitabine and tenofovir disoproxil fumerate with other antiviral medicines in HIV-1-positive treatment-naive adults. The active substances in emtricitabine and tenofovir disoproxil fumerate were more effective than the comparator medicines in reducing the viral load1,2.

The study GS-01-934 compared the combination of emtricitabine and tenofovir disoproxil with the combination of lamivudine and zidovudine (other antiviral medicines) both taken with another antiviral medicine (efavirenz) by patients with HIV-1 infection. Eighty percent of the patients (total of 511) taking emtricitabine and tenofovir disoproxil achieved and maintained viral loads below 50 HIV-1 copies/ml by 48 weeks, compared with 70 % of the patients taking the comparator medicines1,2.

The approvals of emtricitabine/tenofovir disoproxil as pre-exposure prophylaxis (PrEP)

The approvals of emtricitabine / tenofovir disoproxil as pre-exposure prophylaxis (PrEP)

were based on two main studies which evaluated the addition of emtricitabine / tenofovir disoproxil to standard preventative measures for pre-exposure prophylaxis. This was done by comparing emtricitabine / tenofovir disoproxil with placebo in adults at high risk of sexually transmitted HIV-1 infection. Emtricitabine / tenofovir disoproxil resulted more effective than placebo for preventing HIV-1 infection. In both studies the level of protection depended on how well individuals adhered to the treatment program1,2.

Study iPrEx involved 2499 HIV-seronegative individuals with evidence of high-risk behaviour for HIV-1 infection1,2. In total, the study lasted 4,237 person-years (a person-year is a measurement combining the number of persons and their time contribution in a study3). Of the 1,224 people in the emtricitabine/tenofovir disoproxil arm 3.9% tested positive for HIV-1 infection compared with 6.8% individuals taking placebo, corresponding to a relative risk reduction of 42%1,2.

The second study (Partner PrEP) involved over 4,758 heterosexual couples with discordant HIV-1 infection status. Of the individuals takingemtricitabine/tenofovir disoproxil, 0.8 % tested positive for HIV-1 infection over 1 year compared with 3.3 % of those taking placebo1,2.


Shipping Type Standard
Shipping method Standard (not temperature controlled)
This content has been reviewed by our medical doctor Jan de Witt.

How can we help you?

We're ready to answer any question!

Don't speak English? We also speak
Afrikaans, Armenian, Bosnian, Bulgarian, Dutch, German, Italian, Lithuanian, Mandarin, Portuguese, Russian, Serbian, Slovenian, Spanish and Turkish

 

Speak a different language?
Send us a message and we’ll do our best to translate.

 

Our guarantee: We will reply to all messages within 2 hours during office hours.

 

If you want to reach us via phone or chat, please visit our contact page

 

The Social Medwork is registered with the Dutch Ministry of Health in The Hague as an independent intermediary, Registration number 6730 BEM
100% legal and regulated
Registered with the Dutch Ministry of Health as an independent intermediary.

 

Registration number 6730 BEM
Secured logistics globally
• Standard and express delivery (DHL or UPS)
• 24/7 track & trace delivery
• Temperature regulated shipping
Secure payments
All payments are handled securely and are SSL encrypted.
We accept:
Bank transfer & Credit card

 

Patient reviews

 Tomasz Maćkowiak

During the transaction process I was very well informed by the TheSocialMedwork team. They have put as much of their effort to offer best service to me. Moreover the medicine I have ordered was imported two weeks earlier then it was expected. I highly recommend The Social Med Work.

Patient reviews

 Emina Mušović

Thank you for the wonderful cooperation! It's very reserved of us to say we're pleased because you really resolved all our doubts. The medicine has now arrived and we hope it helps. We know we were difficult, with the million different questions but well... That's all behind us now. Strongly recommended! :)

Patient reviews

 Mohamed Rahmat

I am fully satisfied with your online support service. Happy to deal with you.. fast & very fast support.. did not have to wait even 5 minutes! THANK YOU MEDWORK

Questions our patients are asking

visit our support page
You always need a prescription from a doctor based in your country. Other documents, such as an import license from the Ministry of Health, may be needed and depend on your country’s regulations. Contact us and we will provide you with all of the information about the required documents needed for your country.
For prescription medicines you will always need a prescription from your treating doctor. This is to ensure that your treatment is monitored and led by a doctor who is responsible for administering the medicine to you. The prescription is the evidence that your doctor gives you their medical support.
Your order will be shipped to you by our partner couriers, such as DHL, UPS and specialised medicine couriers. If you want us to use a specific courier please inform us when you place your order.
Yes. TheSocialMedwork is registered with the Dutch Ministry of Health as an independent medicines intermediary (registration number 6730 BEM). We always follow your country’s laws and regulations and will discuss any legal requirements with you. We only ship medicines when our patients have a prescription from their treating doctor.
By using TheSocialMedwork you will receive genuine medicines in perfect condition, no matter where you live.
Yes, you are welcome to visit us. We are located in the city centre of Amsterdam at the Herengracht 480. Contact us to schedule the best time for your visit.

 

You can order and receive your
medicine in 5 simple steps

1

Talk to your doctor

2

Place order
and send
prescription

3

Pay for order

4

Check documents
for delivery

5

Receive your medicine

Totally awesome!
Keep up the great
work you’re doing!


Dee Penfold - December 3, 2016
On TheSocialMedwork Facebook

Need a medicine that’s not
approved in your country?

We help patients, physicians and pharmacists acquire the latest life-changing medicines. Not available in your country? No problem - as long as it's approved by a reputable medical authority somewhere, we can help! Contact us today and our experienced team of qualified pharmacists and industry professionals will help you.


learn more
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Medicine information contained herein may be time sensitive. The absence of a warning for a given medicine or combination thereof in no way should be construed to indicate that the medicine or combination is safe, effective or appropriate for any given patient. Always consult your treating physician before starting a course of treatment.